Review article: Pharmacology of esomeprazole and comparisons with omeprazole

Alimentary Pharmacology and Therapeutics, Supplement

Volumn 17, Issue 1, 2003, Pages 5-9

  Dent, J ^a  

^a ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ESOMEPRAZOLE; OMEPRAZOLE; PENTAGASTRIN; PLACEBO;

AREA UNDER THE CURVE; CLINICAL TRIAL; CONFERENCE PAPER; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DELIVERY SYSTEM; DRUG EFFECT; DRUG EFFICACY; GASTROESOPHAGEAL REFLUX; HUMAN; LIVER METABOLISM; PH; PRIORITY JOURNAL; STOMACH ACID SECRETION; TREATMENT OUTCOME;

EID: 0037327934     PISSN: 09530673     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2036.17.s1.2.x     Document Type: Conference Paper

References (12)

1. Hassan-Alin M, Andersson T, Bredberg E, Röhss K. Pharmacokinetics of esomeprazole after oral and intravenous administration of single and repeated doses to healthy subjects, Eur J Clin Pharmacol 2000; 56: 665-70.
2. Lind T, Rydberg L, Kylebäck A, et al. Esomeprazole provides improved acid control vs. omeprazole in patients with symptoms of gastro-oesophageal reflux disease. Aliment Pharmacol Ther 2000; 14: 861-7.
3. Andersson T, Röhss K, Bredberg E, Hassan-Alin M. Pharmacokinetics and pharmacodynamics of esomeprazole, the S-isomer of omeprazole. Aliment Pharmacol Ther 2001; 15: 1563-9.
4. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF. Role of acid and pepsin in acute experimental oesophagitis. Gastroenterology 1969; 56: 223-30.
5. Chiba N, de Gara CJ, Wilkinson JM, Hunt RH. Speed of healing and symptom relief in Grade II to IV gastroesophageal reflux disease: a meta-analysis. Gastroenterology 1997; 112: 1798-810.
6. Holloway RH, Dent J, Narielvala F, Mackinnon A. Relation between oesophageal acid exposure and healing of oesophagitis with omeprazole in patients with severe reflux oesophagitis. Gut 1996; 38: 649-54.
7. Lanzon-Miller S, Pounder RE, Hamilton MR. et al. Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1987; 1: 239-51.
8. Leite LP, Johnston BT, Just RJ, Castell DO. Persistent acid secretion during omeprazole therapy: a study of gastric acid profiles in patients demonstrating failure of omeprazole therapy. Am J Gastroenterol 1996; 91: 1527-31.
9. Johnsson L, Adloum W, Johnsson F, Joelsson B. Timing of reflux symptoms and esophageal acid exposure. Gullet 1992; 2: 58-62.
10. Robertson D, Aldersley M, Shepherd H, Smith CL. Patterns of acid reflux in complicated oesophagitis. Gut 1987; 28: 1484-8.
11. Adachi K, Fujishiro H, Katsube T, et al. Predominant nocturnal acid reflux in patients with Los Angeles grade C and D reflux esophagitis. J Gastroenterol Hepatol 2001; 16: 1191-6.
12. Hatlebakk JG. Review article: gastric acidity - comparison of esomeprazole with other proton pump inhihitors. Aliment Pharmacol Ther 2003; 17(Suppl. 1): 10-15.